Fri, September 27, 2024
[ 12:00 AM ] - WOPRAI
Wed, August 7, 2024
[ 12:00 AM ] - WOPRAI
Thu, May 16, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 1, 2024
[ 12:00 AM ] - WOPRAI
Mon, April 1, 2024
[ 12:00 AM ] - WOPRAI
Thu, March 28, 2024
[ 12:00 AM ] - WOPRAI
Wed, March 13, 2024
[ 12:00 AM ] - WOPRAI
Tue, June 13, 2023
[ 12:00 AM ] - WOPRAI
Mon, April 3, 2023
[ 12:00 AM ] - WOPRAI
Fri, March 3, 2023
[ 12:00 AM ] - WOPRAI
Tue, February 28, 2023
[ 12:00 AM ] - WOPRAI
Tue, November 22, 2022
Tue, March 15, 2022
[ 12:00 AM ] - WOPRAI
Wed, March 9, 2022
[ 12:00 AM ] - WOPRAI
Wed, January 5, 2022
[ 12:00 AM ] - WOPRAI
Wed, February 3, 2021
[ 12:00 AM ] - WOPRAI
Mon, January 11, 2021
[ 12:00 AM ] - WOPRAI
Wed, October 31, 2018
[ 12:00 AM ] - WOPRAI
Thu, September 20, 2018
[ 12:00 AM ] - WOPRAI
Thu, May 24, 2018
[ 12:00 AM ] - WOPRAI
Wed, August 7, 2013
Alexander Nowak Maintained (BVS) at Strong Buy with Increased Target to $17 on, Sep 27th, 2024
Alexander Nowak of Craig-Hallum, Maintained "Bioventus Inc." (BVS) at Strong Buy with Increased Target from $12 to $17 on, Sep 27th, 2024.
Alexander has made no other calls on BVS in the last 4 months.
There is 1 other peer that has a rating on BVS. Out of the 1 peers that are also analyzing BVS, 0 agree with Alexander's Rating of Hold.
This is the rating of the analyst that currently disagrees with Alexander
- William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $12 on, Tuesday, August 13th, 2024
Contributing Sources